Share
- Release Date: 01/10/13 14:14
- Summary: OFFICE: ATM: Appointment to new role of GM Asia
- Price Sensitive: No
- Download Document 2.49KB
ATM
01/10/2013 11:14
OFFICE
REL: 1114 HRS A2 Corporation Limited
OFFICE: ATM: Appointment to new role of GM Asia
The Board of A2 Corporation is pleased to announce that Philip Wohlsen is to
join the company in a newly established role of General Manager Asia,
reporting to myself.
The development of business opportunities within Asia is a key strategic
priority for the Company. At present the company is focused on the sale of A2
branded infant formula products into China and developing new opportunities
for UHT milk. This new role will assume overall responsibility for managing
the profitable development of the current business and developing new growth
initiatives within the region. The role will be based in Sydney.
The establishment of this role is consistent with the model of driving growth
through a regionally focused structure supported by appropriate corporate
functions.
Philip joins A2C with an outstandingly strong skill set in marketing and
sales and business development in Australia and Asia. His previous roles
have included:
o Asia Pacific Franchise Director, OTC and Consumer Healthcare, Johnson &
Johnson based in Singapore which involved developing growth and innovation
strategies for market leading brands including Tylenol, Nicorette, Benadryl,
Listerine and Band Aid. His achievements included repositioning and
relaunching China's OTC brands combined with a major geographic expansion
program, significant improvement in quality of marketing communications and
development of a pipeline of innovations focused on emerging markets. Philip
also developed an effective management team which increased resource and
capability for the J&J businesses in the region.
o Previous to this, he was Marketing Director with Pfizer involved in the
development of their consumer health brands. His contributions included
development of a disciplined consumer insight and marketing based approach to
achieve consistent growth of the group's leading brands. He also successfully
led the re-launch of the OTC Respiratory Health business through a period of
regulatory change.
o Previously to this he was New Business Development Manager with Campbell
Arnotts Group, Account Director with J Walter Thompson and held a number of
trade and brand management roles at Unilever.
Philip will commence his new role in early January 2014.
For further information contact:
Geoffrey Babidge
Managing Director
A2 Corporation Limited
+61 2 96977008
A2 Corporation Limited
End CA:00241837 For:ATM Type:OFFICE Time:2013-10-01 11:14:10
